首页> 外文OA文献 >Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
【2h】

Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.

机译:末端补体途径在兔实验性膜性肾病中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our recent observations of a complement-mediated, cell-independent mechanism of altered glomerular permeability in rat membranous nephropathy suggested a possible role for the terminal complement pathway in the mediation of proteinuria in certain forms of glomerular disease. To directly determine whether the membranolytic terminal complement components (C5b-C9) are involved in glomerular injury, we studied the development of proteinuria in normal and C6-deficient (C6D) rabbits, in both of which a membranous nephropathy-like lesion develops early in the course of immunization with cationized bovine serum albumin (cBSA) (pI 8.9-9.2). C6 hemolytic activity of C6D was 0.01% that of control rabbits. After 1 wk of daily intravenous injections of cBSA, proteinuria developed in 71% of controls (median 154, range 1-3,010 mg/24 h, n = 24), whereas none of C6D were proteinuric (median 6, range 2-12 mg/24 h, n = 12, P less than 0.01). After 1 wk of cBSA, both groups had qualitatively identical glomerular deposits of BSA, rabbit IgG, and C3 on immunofluorescence microscopy, predominantly subepithelial electron-dense deposits on electron microscopy, and minimal glomerular inflammatory cell infiltration of glomeruli. Glomeruli were isolated from individual animals after 1 wk of cBSA and deposits of rabbit IgG antibody were quantitated by a standardized in vitro assay using anti-rabbit IgG-125I. Rabbit IgG deposits were found to be similar in control (29.8 +/- 13.2, range 12.7-48.6 micrograms anti-IgG/2,000 glomeruli, n = 6) and C6D rabbits (32.6 +/- 13.8, range 16.8-48.8 micrograms anti-IgG/2,000 glomeruli, n = 5, P greater than 0.05). After 2 wk, coincident with a prominent influx of mononuclear cells and neutrophils, proteinuria developed in C6D rabbits. These results document, for the first time, a requirement for a terminal complement component in the development of immunologic glomerular injury. Since the only known action of C6 is in the assembly of the membrane attack complex, these observations suggest that the membranolytic properties of complement may contribute to glomerular damage.
机译:我们最近对大鼠膜性肾病中肾小球通透性改变的补体介导的细胞独立机制的观察表明,终末补体途径可能在某些形式的肾小球疾病中介导蛋白尿。为了直接确定膜溶解性末端补体成分(C5b-C9)是否参与肾小球损伤,我们研究了正常兔和C6缺乏型(C6D)兔的蛋白尿发育,在这两种兔中,膜性肾病样病变均在早期发展。阳离子化牛血清白蛋白(cBSA)免疫过程(pI 8.9-9.2)。 C6D的C6溶血活性为对照兔的0.01%。每天静脉注射cBSA 1周后,在71%的对照中出现蛋白尿(中位数154,范围1-3010 mg / 24 h,n = 24),而C6D均无蛋白尿(中位数6,范围2-12 mg)。 / 24 h,n = 12,P小于0.01)。在cBSA 1周后,两组在免疫荧光显微镜下的BSA,兔IgG和C3的肾小球质量均相同,在电子显微镜下主要为上皮下电子致密性沉积,肾小球的最小肾小球炎性细胞浸润。在1周的cBSA后,从个体动物中分离出肾小球,并使用抗兔IgG-125I通过标准化的体外测定来定量兔IgG抗体的沉积。发现对照组中的兔IgG沉积物相似(29.8 +/- 13.2微克,抗IgG / 2,000肾小球,范围12.7-48.6微克,n = 6)和C6D兔(32.6 +/- 13.8,16.8-48.8微克,抗IgG / 2,000肾小球,n = 5,P大于0.05)。 2周后,伴随着单核细胞和中性粒细胞的大量涌入,蛋白尿在C6D兔中发展。这些结果首次证明在免疫性肾小球损伤的发展中需要末端补体成分。由于C6唯一已知的作用是在膜攻击复合物的组装中,这些观察结果表明补体的膜分解特性可能有助于肾小球损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号